Tag Archives: FDA

Plot twists in Soderbergh’s new movie Side Effects strain belief

Share I went to see Steven Soderbergh’s new film, Side Effects, with anticipation and dread. The movie, after all, carries the same name as my 2008 book, Side Effects and from what I could tell of the trailers, its plot … Continue reading

Posted in antidepressants, drug marketing, FDA, pharmaceutical industry, prescription drug abuse, university industry collaboration | Tagged , , , , , , , , | 2 Comments

Fast-moving bill in Congress would weaken FDA oversight of new drugs and devices

Share Congress is moving quickly to pass a bill that would authorize higher industry fees for the FDA in exchange for speeding up the approval of some drugs and medical devices and eliminating restrictions on financial conflicts of interest among … Continue reading

Posted in clinical trials, conflicts of interest, drug marketing, FDA, medical devices, pharmaceutical industry, public health | Tagged , , , , , | 1 Comment

Institute of Medicine report concludes that the FDA is not doing adequate job of assessing drug benefits and risks

Share Two weeks ago, I headlined my blog with this question: Is the FDA violating its own mandate to approve safe drugs? Four days later, the national Institute of Medicine (IOM) released a 233-page report concluding that FDA’s current approach … Continue reading

Posted in antidepressants, clinical trials, drug marketing, FDA, media coverage, National Institutes of Health, patient care, pharmaceutical industry, Uncategorized | Tagged , , , , , , , | 1 Comment

Is the FDA violating its own mandate to approve safe drugs?

Share Is the Food and Drug Administration violating its own mandate to approve safe drugs? That was the question that Donald Light, co-author of The Risk for Prescription Drugs and a long-time medical sociologist, posed at a talk yesterday at … Continue reading

Posted in antidepressants, biotech industry, clinical trials, continuing medical education, drug marketing, FDA, health care costs, medical devices, patient care, pharmaceutical industry, scientific misconduct, suicide rates, Uncategorized | Tagged , , , , , , , , , | 2 Comments

How drug companies continue to hide the true story of Tamiflu and other drugs from the American public

Share I’ve been reading Dr. David Healy’s new book, Pharmageddon, and while some of it may seem like old news, I was struck by his fresh analysis of how the pharmaceutical industry has turned the original purpose of clinical trials … Continue reading

Posted in antidepressants, antipsychotic drugs, clinical trials, drug marketing, FDA, health care costs, patient care, pharmaceutical industry, scientific misconduct | Tagged , , , , , , , , | 1 Comment

Deceptive drug research practices explain why over-medicating of children still going on

Share A new report from the U.S. Government Accountability office confirms something that Rose Firestein, the eponymous prosecutor in the title of Side Effects: A Prosecutor, a Whistleblower and Bestselling Antidepressant on Trial noticed way back in the ’90s: that … Continue reading

Posted in antidepressants, antipsychotic drugs, clinical trials, conflicts of interest, drug marketing, FDA, ghostwriting, pharmaceutical industry | Tagged , , , , , , | 3 Comments

Drug and medical device industry launches push to weaken FDA oversight

Share With the Obama administration hobbled by a Republican-led Congress, the pharmaceutical and medical device industry seems to have launched a concerted push to roll back regulatory initiatives designed to protect consumers from unproven or unsafe drugs and medical devices. … Continue reading

Posted in antidepressants, conflicts of interest, FDA, medical devices, suicide rates | Tagged , , , , , | 2 Comments